MONTREAL, QUEBEC -- (MARKET WIRE) -- March 23, 2007 -- ART Advanced Research Technologies Inc. (ART) (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today announces its financial results for the fourth quarter and year ended December 31, 2006. Revenues for the fourth quarter of 2006 were $628,907, compared to $1,239,700 for the same quarter a year ago. Revenues for the year ended December 31, 2006 were $3,081,776, compared to $4,125,550 for the year ended December 31, 2005. The net income for the three-month period ended December 31, 2006 was $1,354,770 or $0.03 per share, compared to a net loss of $3,313,319 or $0.08 per share for the three-month period ended December 31, 2005. The net loss for the year ended December 31, 2006 was $8,754,767 or $0.18 per share, compared to $13,129,184 or $0.31 per share for the year ended December 31, 2005. All dollar amounts referenced herein are in US dollars, unless otherwise stated.
